These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 16379503

  • 1. Neuroleptic malignant syndrome associated with risperidone in a male with early-onset schizophrenia.
    Mané A, Baeza I, Morer A, Lázaro ML, Bernardo M.
    J Child Adolesc Psychopharmacol; 2005 Dec; 15(6):844-5. PubMed ID: 16379503
    [No Abstract] [Full Text] [Related]

  • 2. [Neuroleptic malignant syndrome].
    Charra B, Nejmi H, Hachimi A, Benslama A, Motaouakkil S.
    Ann Fr Anesth Reanim; 2006 May; 25(5):542-3. PubMed ID: 16488105
    [No Abstract] [Full Text] [Related]

  • 3. Neuroleptic malignant syndrome associated with risperidone long-acting injection: a case report.
    Yamashita T, Fujii Y, Misawa F.
    J Clin Psychopharmacol; 2013 Feb; 33(1):127-9. PubMed ID: 23288234
    [No Abstract] [Full Text] [Related]

  • 4. NMS after clozapine initiation.
    Skarpathiotakis M, Westreich N.
    J Am Acad Child Adolesc Psychiatry; 2005 Nov; 44(11):1101-2. PubMed ID: 16239854
    [No Abstract] [Full Text] [Related]

  • 5. Novel antipsychotics and the neuroleptic malignant syndrome: a review and critique.
    Hasan S, Buckley P.
    Am J Psychiatry; 1998 Aug; 155(8):1113-6. PubMed ID: 9699705
    [Abstract] [Full Text] [Related]

  • 6. Risperidone-induced hyperamylasemia, hyperlipasemia, and neuroleptic malignant syndrome: a case report.
    Ghio L, Fornaro G, Rossi P.
    J Clin Psychopharmacol; 2009 Aug; 29(4):391-2. PubMed ID: 19593182
    [No Abstract] [Full Text] [Related]

  • 7. Risk for definite neuroleptic malignant syndrome. A prospective study in 223 consecutive in-patients.
    Hermesh H, Aizenberg D, Weizman A, Lapidot M, Mayor C, Munitz H.
    Br J Psychiatry; 1992 Aug; 161():254-7. PubMed ID: 1355693
    [Abstract] [Full Text] [Related]

  • 8. Neuroleptic Malignant Syndrome After Early Administration of Risperidone Long-Acting Injection.
    Mitchell BG, McMahon BC, Mitchell CW.
    Prim Care Companion CNS Disord; 2017 Nov 30; 19(6):. PubMed ID: 29195036
    [No Abstract] [Full Text] [Related]

  • 9. Extreme elevation of creatinine phosphokinase levels in neuroleptic malignant syndrome associated with atypical antipsychotics.
    Ladds B, Thomas P, Mejia C, Hauser D.
    Am J Psychiatry; 2009 Jan 30; 166(1):114-5. PubMed ID: 19122020
    [No Abstract] [Full Text] [Related]

  • 10. Neuroleptic malignant syndrome and risperidone: a case report.
    Bonwick RJ, Hopwood MJ, Morris PL.
    Aust N Z J Psychiatry; 1996 Jun 30; 30(3):419-21. PubMed ID: 8839956
    [Abstract] [Full Text] [Related]

  • 11. Catatonia and mild neuroleptic malignant syndrome after initiation of long-acting injectable risperidone: case report.
    Mall GD, Hake L, Benjamin AB, Adityanjee A.
    J Clin Psychopharmacol; 2008 Oct 30; 28(5):572-3. PubMed ID: 18794658
    [No Abstract] [Full Text] [Related]

  • 12. Atypical neuroleptic malignant syndrome associated with iloperidone administration.
    Guanci N, Aggarwal R, Schleifer S.
    Psychosomatics; 2012 Oct 30; 53(6):603-5. PubMed ID: 23157999
    [No Abstract] [Full Text] [Related]

  • 13. A case of neuroleptic malignant syndrome with clozapine and risperidone.
    Beauchemin MA, Millaud F, Nguyen KA.
    Can J Psychiatry; 2002 Nov 30; 47(9):886. PubMed ID: 12500761
    [No Abstract] [Full Text] [Related]

  • 14. Neuroleptic malignant syndrome associated with risperidone and olanzapine in first-episode schizophrenia.
    Aboraya A, Schumacher J, Abdalla E, LePage J, McGhee M, Butcher D, Griffin H, Shahda M.
    W V Med J; 2002 Nov 30; 98(2):63-5. PubMed ID: 12048741
    [Abstract] [Full Text] [Related]

  • 15. Case study. Risperidone-Induced neuroleptic malignant syndrome in an adolescent.
    Robb AS, Chang W, Lee HK, Cook MS.
    J Child Adolesc Psychopharmacol; 2000 Nov 30; 10(4):327-30. PubMed ID: 11191694
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Fever, confusion, acute kidney injury: is this atypical neuroleptic malignant syndrome following polypharmacy with clozapine and risperidone?
    Cherry S, Siskind D, Spivak V, Wysoczanski D, Halangoda P.
    Australas Psychiatry; 2016 Dec 30; 24(6):602-603. PubMed ID: 27194777
    [Abstract] [Full Text] [Related]

  • 18. [The risperidone-associated neuroleptic malignant syndrome in a pediatric patient].
    Villanueva Lamas J, García García J, Alda Diez JA, Tous Andreu N.
    An Esp Pediatr; 1998 Dec 30; 49(6):652-3. PubMed ID: 9972639
    [No Abstract] [Full Text] [Related]

  • 19. Atypical neuroleptic malignant syndrome with clozapine and subsequent haloperidol treatment.
    Spivak M, Adams B, Crockford D.
    Can J Psychiatry; 2003 Feb 30; 48(1):66. PubMed ID: 12635570
    [No Abstract] [Full Text] [Related]

  • 20. Use of novel antipsychotic drugs.
    Raleigh F.
    Pharmacotherapy; 1996 Feb 30; 16(6 Pt 2):160S-165S; discussion 166S-168S. PubMed ID: 8948000
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.